Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$32.49 USD
+0.25 (0.78%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $32.51 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
SGRY 32.49 +0.25(0.78%)
Will SGRY be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SGRY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SGRY
Surgery Partners (SGRY) Meets Q2 Earnings Estimates
Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?
SGRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
SGRY or MEDP: Which Is the Better Value Stock Right Now?
SGRY vs. MEDP: Which Stock Is the Better Value Option?
Wall Street Analysts Think Surgery Partners (SGRY) Could Surge 57.53%: Read This Before Placing a Bet
Other News for SGRY
Surgery Partners: Buyout Rumors And Consistent Growth
Janus Henderson High-Yield Fund Q2 2024 Commentary
What's Driving LifeStance Health Group Inc's Surprising 15% Stock Rally?
Benchmark Co. Sticks to Their Buy Rating for Surgery Partners (SGRY)
Surgery Partners jumps after report of interest from UnitedHealth, TPG